Skip to main content

Advertisement

SpringerLink
Log in

The role of hyperthermia in combined treatment in the management of soft tissue sarcoma

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve outcome with regard to local control and overall survival. Systemic chemotherapy has been integrated either after (adjuvant) or before (neoadjuvant) optimal local treatment by surgery and radiotherapy in HR-STS. This short overview summarizes the results of the combination with regional hyperthermia as a new treatment strategy to open a new therapeutic window.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Kattan MW, Leung DH, Brennan MF: Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002, 20:791–796. Critical analysis of prognostic factors and creation of a nomogram.

    Article  PubMed  Google Scholar 

  2. Pisters PW, Leung DH, Woodruff J, et al.: Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996, 14:1679–1689.

    PubMed  CAS  Google Scholar 

  3. Stoeckle E, Coindre JM, Bonvalot S, et al.: Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001, 92:359–368.

    Article  PubMed  CAS  Google Scholar 

  4. Grobmyer SR, Make RG, Demetri GD, et al.: Neoadjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 2004, 15:1667–1672. Non-randomized comparison with local therapy only.

    Article  PubMed  CAS  Google Scholar 

  5. Spiro IJ, Suit H, Gebhardt M, et al.: Neoadjuvant chemotherapy and radiotherapy for large soft tissue sarcomas [abstract]. Proc ASCO 1996, 15:524 (abstract 168).

    Google Scholar 

  6. Kraybill WG, Harris J, Spiro IJ, et al.: Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas on the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 2006, 24:619–625. Grade 4 hematologic and nonhematologic toxicities occurred in 78% and 19% of patients, respectively.

    Article  PubMed  CAS  Google Scholar 

  7. Gortzak E, Azzarelli A, Buesa J, et al.: A randomised Phase II study on neoadjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma. Eur J Cancer 2001, 37:1096–1103. New therapeutic option in a multimodal treatment strategy with low toxicity.

    Article  PubMed  CAS  Google Scholar 

  8. Wust P, Hildebrandt B, Sreenivasa G, et al.: Hyperthermia in combined treatment of cancer. Lancet Oncol 2002, 3:487–497. Excellent review on the state of the art of hyperthermia.

    Article  PubMed  CAS  Google Scholar 

  9. Issels RD, Prenninger SW, Nagele A, et al.: Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. J Clin Oncol 1991, 8:1818–1829.

    Google Scholar 

  10. Issels RD, Mittermueller J, Gerl A, et al.: Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients. J Cancer Res Clin Oncol 1991, 117(Suppl IV):141–147

    Article  Google Scholar 

  11. Issels RD, Abdel-Rahman S, Wendtner CM, et al.: Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk soft tissue sarcomas (HR-STS) of adults: long-term results of a phase II study. Eur J Cancer 2001, 37:1599–1608. First long-term analysis for RHT combined with chemotherapy outcome in STS patients.

    Article  PubMed  CAS  Google Scholar 

  12. Wendtner CM, Abdel-Rahman S, Baumert J, et al.: Treatment of primary, recurrent or inadequately resected high-risk soft tissue sarcomas (HR-STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur J Cancer 2001, 37:1609–1616.

    Article  PubMed  CAS  Google Scholar 

  13. Wendtner CM, Abdel-Rahman S, Krych M, et al.: Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol 2002, 20:3156–3164. First report on prognostic importance of initial response to preoperative combined hyperthermic chemotherapy for survival.

    Article  PubMed  CAS  Google Scholar 

  14. Lindner LH, Schlemmer M, Hohenberger P, et al.: First interim report on the randomized EORTC 62961/ ESHORHT 95 Intergroup Study (Phase III) combined with regional hyperthermia (RHT) versus chemotherapy alone in the treatment of high-risk soft tissue sarcomas (HR-STS) in adults. J Clin Oncol 2004, 23(Suppl):817 (abstract 9015).

    Google Scholar 

  15. Lindner LH, Schlemmer M, Hohenberger P, et al.: Risk assessment of early progression among 213 pts with high-risk soft tissue sarcomas (HR-STS) treated with neoadjuvant chemotherapy ‡ regional hyperthermia: EORTC 62961/ESHO-RHT 95 Intergroup phase III study. J Clin Oncol (Suppl) 23(16S):820s (abstract 9020). Overall risk for early progression during or after preoperative chemotherapy with or without regional hyperthermia is 15%.

Download references

Author information

Authors and Affiliations

  1. University Hospital Medical Center Grosshadern Medical Clinic III, and GSF-National Research Center for the Environment and Health, 81377, Munich, Germany

    Rolf D. Issels MD, PhD

Authors
  1. Rolf D. Issels MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcus Schlemmer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lars H. Lindner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rolf D. Issels MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Issels, R.D., Schlemmer, M. & Lindner, L.H. The role of hyperthermia in combined treatment in the management of soft tissue sarcoma. Curr Oncol Rep 8, 305–309 (2006). https://doi.org/10.1007/s11912-006-0037-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-006-0037-1

Keywords

Search

Navigation